Drug-eluting balloons (DEBs) were developed as an alternative to drug-eluting stents for the treatment of coronary artery disease. DEBs work by temporarily delivering an anti-proliferative drug, such as paclitaxel, during balloon angioplasty to prevent restenosis. This localized drug delivery allows for higher drug concentrations at the site of injury while avoiding systemic drug exposure.How...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian